Invention Grant
- Patent Title: Oxazolidinone-quinolone hybrid antibacterial for the parenteral treatment of prophylaxis of bacterial diseases
-
Application No.: US16908244Application Date: 2020-06-22
-
Publication No.: US11261205B2Publication Date: 2022-03-01
- Inventor: Thomas Kapsner , Axel Dalhoff , Thomas Gramatte
- Applicant: Morphochem GmbH
- Applicant Address: DE Munich
- Assignee: Morphochem GmbH
- Current Assignee: Morphochem GmbH
- Current Assignee Address: DE Munich
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Gang Wang
- Priority: EP13002762 20130528,EP13005745 20131210,EP13005748 20131210
- Main IPC: C07F9/653
- IPC: C07F9/653 ; A61K31/4709 ; A61K31/4375 ; A61P31/04 ; A61P31/00 ; A61P1/12 ; A61P1/00
Abstract:
The present invention relates to the use of oxazolidinone-quinolone hybrids for the parenteral (especially intravenous) treatment or prophylaxis of bacterial diseases. The present invention relates moreover to improved methods of administering oxazolidinone-quinolone hybrid antibacterials.
Information query
